fda approved glp-1 drugs for weight loss New Pill Foundayo (Orforglipron) Gets Approval Obesity How GLP-1 medications are transforming

The complex pathophysiology and the metabolic risk factors shared between type 2 diabetes, obesity, CKD and cardiovascular disease have led to the concept of a cardiovascularkidneymetabolic (CKM) syndrome

The subsequent clinical success of engineered dual and triple incretin agonists has fundamentally altered the interpretation of these early findings

In addition, GLP-1 RAs are particularly effective in reducing HbA1c, which is especially relevant as HbA1c levels 6.5% have been shown to be associated with increased incidence of microvascular complications [69] while it is challenging to achieve HbA1c levels 30 ml/min/1.73 m 2 [2], with a GLP-1 RA as the preferred agent if additional therapy is needed for glycemic control

Stonestreet cautions, "Don't say, 'Man, I'm going to run a marathon,' or 'I'm never going to have a piece of candy again in my life.'" Instead, he recommends taking life "bit by bit" (via Business Insider).

FAQ What is the best GLP-1 provider

When you take creatine, your creatinine goes up, not because your kidneys are struggling, but because there is simply more creatine being metabolized